242 related articles for article (PubMed ID: 10768952)
1. Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal.
Oeuvray C; Theisen M; Rogier C; Trape JF; Jepsen S; Druilhe P
Infect Immun; 2000 May; 68(5):2617-20. PubMed ID: 10768952
[TBL] [Abstract][Full Text] [Related]
2. Pattern of antibodies to the Duffy binding like domain of Plasmodium falciparum antigen Pf332 in Senegalese individuals.
Balogun HA; Awah N; Nilsson S; Rogier C; Trape JF; Chen Q; Roussilhon C; Berzins K
Acta Trop; 2014 Feb; 130():80-7. PubMed ID: 24200839
[TBL] [Abstract][Full Text] [Related]
3. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.
Soe S; Theisen M; Roussilhon C; Aye KS; Druilhe P
Infect Immun; 2004 Jan; 72(1):247-52. PubMed ID: 14688102
[TBL] [Abstract][Full Text] [Related]
4. Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria.
Dodoo D; Theisen M; Kurtzhals JA; Akanmori BD; Koram KA; Jepsen S; Nkrumah FK; Theander TG; Hviid L
J Infect Dis; 2000 Mar; 181(3):1202-5. PubMed ID: 10720556
[TBL] [Abstract][Full Text] [Related]
5. Antibody Correlates of Protection from Clinical
Hamre KES; Ondigo BN; Hodges JS; Dutta S; Theisen M; Ayodo G; John CC
Am J Trop Med Hyg; 2020 Dec; 103(6):2174-2182. PubMed ID: 33124533
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.
Mamo H; Esen M; Ajua A; Theisen M; Mordmüller B; Petros B
Malar J; 2013 Feb; 12():51. PubMed ID: 23383869
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
[TBL] [Abstract][Full Text] [Related]
8. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC
Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.
Roussilhon C; Oeuvray C; Müller-Graf C; Tall A; Rogier C; Trape JF; Theisen M; Balde A; Pérignon JL; Druilhe P
PLoS Med; 2007 Nov; 4(11):e320. PubMed ID: 18001147
[TBL] [Abstract][Full Text] [Related]
10. The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro.
Theisen M; Soe S; Oeuvray C; Thomas AW; Vuust J; Danielsen S; Jepsen S; Druilhe P
Infect Immun; 1998 Jan; 66(1):11-7. PubMed ID: 9423833
[TBL] [Abstract][Full Text] [Related]
11. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
12. Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission.
Lusingu JP; Vestergaard LS; Alifrangis M; Mmbando BP; Theisen M; Kitua AY; Lemnge MM; Theander TG
Malar J; 2005 Sep; 4():48. PubMed ID: 16194274
[TBL] [Abstract][Full Text] [Related]
13. Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity.
Theisen M; Dodoo D; Toure-Balde A; Soe S; Corradin G; Koram KK; Kurtzhals JA; Hviid L; Theander T; Akanmori B; Ndiaye M; Druilhe P
Infect Immun; 2001 Sep; 69(9):5223-9. PubMed ID: 11500389
[TBL] [Abstract][Full Text] [Related]
14. Understanding human-Plasmodium falciparum immune interactions uncovers the immunological role of worms.
Roussilhon C; Brasseur P; Agnamey P; Pérignon JL; Druilhe P
PLoS One; 2010 Feb; 5(2):e9309. PubMed ID: 20174576
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma haematobium infection affects Plasmodium falciparum-specific IgG responses associated with protection against malaria.
Courtin D; Djilali-Saïah A; Milet J; Soulard V; Gaye O; Migot-Nabias F; Sauerwein R; Garcia A; Luty AJ
Parasite Immunol; 2011 Feb; 33(2):124-31. PubMed ID: 21226725
[TBL] [Abstract][Full Text] [Related]
16. HIV infection drives IgM and IgG3 subclass bias in Plasmodium falciparum-specific and total immunoglobulin concentration in Western Kenya.
Odhiambo EO; Datta D; Guyah B; Ayodo G; Ondigo BN; Abong'o BO; John CC; Frosch AEP
Malar J; 2019 Aug; 18(1):297. PubMed ID: 31470903
[TBL] [Abstract][Full Text] [Related]
17. Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium.
Mutapi F; Roussilhon C; Mduluza T; Druilhe P
Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):405-9. PubMed ID: 17568947
[TBL] [Abstract][Full Text] [Related]
18. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.
Dodoo D; Atuguba F; Bosomprah S; Ansah NA; Ansah P; Lamptey H; Egyir B; Oduro AR; Gyan B; Hodgson A; Koram KA
Malar J; 2011 May; 10():108. PubMed ID: 21529376
[TBL] [Abstract][Full Text] [Related]
19. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa.
Nebie I; Diarra A; Ouedraogo A; Soulama I; Bougouma EC; Tiono AB; Konate AT; Chilengi R; Theisen M; Dodoo D; Remarque E; Bosomprah S; Milligan P; Sirima SB
Infect Immun; 2008 Feb; 76(2):759-66. PubMed ID: 18070896
[TBL] [Abstract][Full Text] [Related]
20. Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.
Hermsen CC; Verhage DF; Telgt DS; Teelen K; Bousema JT; Roestenberg M; Bolad A; Berzins K; Corradin G; Leroy O; Theisen M; Sauerwein RW
Vaccine; 2007 Apr; 25(15):2930-40. PubMed ID: 16914240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
